Navigation Links
Scientists in Hungary and Portugal get research boost
Date:7/29/2008

Heidelberg, 29 July 2008 Two talented life scientists will receive EMBO Installation Grants, assisting them to establish their research groups in Hungary and Portugal. These two scientists will receive funding in 2008 similar to the previous nine awardees announced in November 2007. The European Molecular Biology Organization (EMBO) introduced the scheme in 2006.

EMBO Installation Grants are awarded annually and aim to strengthen science in selected member states of the EMBC, the EMBO intergovernmental funding body. The EMBC Member States hosting the grantees generally finance the grants entirely. EMBC Member States participating in the scheme include Croatia, the Czech Republic, Estonia, Hungary, Poland, Portugal and Turkey.

Each scientist receives 50,000 euro annually for three to five years to help them establish their groups and themselves in the European scientific community. Grantees are integrated into the prestigious EMBO Young Investigator network, providing networking opportunities with some of Europe's best young group leaders and a range of career development programmes.

"EMBO congratulates these two scientists as recipients of the 2007 EMBO Installation Grants and welcomes them to the EMBO community," said Hermann Bujard, EMBO Executive Director. "These talented scientists will benefit from the secure financial backing of their host countries plus the active interest and support of EMBO in their scientific and professional development. They represent a promising scientific future for the countries receiving them and for Europe as a whole."

A committee of EMBO Members selected the successful candidates for the high standard of their research. By bringing this level of scientific talent into the participating countries, EMBO hopes to improve the competitiveness of these countries in European science.

Gergely Szakcs is moving from the USA to set up his laboratory at the Hungarian Academy of Sciences in B
'/>"/>

Contact: Suzanne Beveridge
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists break record by finding northernmost hydrothermal vent field
2. Scientists suspect omega-3 fatty acids could slow acute wound healing
3. Durham scientists to tackle CO2 storage in global warming challenge
4. Licking your wounds: Scientists isolate compound in human saliva that speeds wound healing
5. Training future scientists at the Ecological Society of Americas 93rd Annual Meeting
6. Gladstone scientists create Wikipathways to foster research collaboration
7. Nature publishes new evidence about the deep biosphere written by biogeoscientists
8. ASBMB taps 8 scientists for top awards
9. When fish talk, scientists listen
10. Scientists demonstrate the sharpest measurement of ice crystals in clouds
11. Scientists demonstrate means of reducing Alzheimers-like plaques in fly brain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ass., Oct. 20 Aware, Inc...d technology and biometrics software, today report...September 30, 2009. ,, Michael Tzannes, Aware...rlier today, we announced an agreement to sell our...a new fabless semiconductor company being spun out...
(Date:11/4/2009)..., Oct. 26 BIO-key Intern... in finger-based biometric identification software...s at the AABB TXPO conference being held at the Ne...9. BIO-key will provide hands-on product demonstra...ology in booth #424. Also, at 5 PM on Monday, Octo...
(Date:11/4/2009)...Calif., Nov. 4 GenVault Corporatio...y, M.D., Ph.D., has joined its Board of Directors....f the Salk Institute, is an acclaimed physician-sc...he Salk Institute, Dr. Brody served as president o... the National Academy of Engineering and the Insti...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 1School Closures May Not Be Necessary When Swine Flu Strikes 53955 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 3School Closures May Not Be Necessary When Swine Flu Strikes 53955 4
..., Mass. (Oct. 20, 2008) -- Two teams of scientists...echnology (HST) at Brigham and Women,s Hospital ha...elivery system that is biocompatible, efficient at...ese structures can deliver clinically approved dru...rs for the drug or generating toxic components, a ...
...chers are on the verge of unleashing the power of ... therapies, as decades of research begins to bear ... best kept secrets, but is now attracting fast gro...rmaceutical industry in the quest for novel drugs ...lly overcoming limitations and side effects of cur...
...thers purposely expose their offspring to their ow...use it is widely accepted that exposure to materna...ative impacts on offspring following birth. To exa...pen, evolutionary physiologists Oliver Love and To... maternally-derived stress hormone corticosterone ...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2
(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)...stria, November 6 EUCODIS Bioscien...ng, and marketing enzymes for the,chemical industr...rch,agreement with Bio Sidus, the leading biopharm... agreement gives EUCODIS Bioscience exclusive acce...o Sidus, proprietary collection of,psychrophilic b...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc....any") today announced updated results from a Phase...ith sarcomas metastatic to the lung in a poster pr...cology Society Meeting held in Miami Beach, Florid...on, entitled "A Phase II Study of Intravenous REOL...
(Date:11/5/2009)...-- Gone hybrid . . . , Fuel economy ratings fo...ed at the www.fueleconomy.gov web site, which Oa...s for the U.S. Department of Energy and the U.S. E... vehicles on the best fuel economy list are hybrid...48 highway). "This list proves that hybrids have g...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...iences Inc. today announced the development of a u...g from tissue hydration to the passivation of medi...is a series of patent-pending polymers that allow ... angle," says Andrew Loxley, PS, Director of New T...ed the system to develop an ocular formulation for...
...chnology today announced,that the company has obta...utilize Merck Eprova,s proprietary chiral lipid DO...ts in development based on the Versamune(TM),techn...oride shows enhanced,adjuvant activity compared to...enantiomerically pure DOTAP Chloride manufactured ...
...ork Sciences, Inc. (GNS) today announced that it h...Executive Officer of Stromedix, Inc. and former Ex... to its Board of Directors. , , Dr. Gilman has ...dix since June 2006. He was previously Executive ... Biogen in 1999 as Director of Molecular Biology a...
Other Biology Technology:Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Gene Network Sciences Announces Michael Gilman as Board Member 2
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...quadrupole 1200L sets the new standard for value i...ng the latest technologies and providing tailored ... needs. The Atmospheric Pressure Ionization (API)...r provide superior selectivity and sensitivity for...
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Biology Products: